CASP3 and hereditary elliptocytosis: DAPA markedly reduced the protein expression caspase-3 in the brain, suggesting a neuroprotective effect that may involve inhibiting ROS production and apoptotic pathways triggered by TLR-4 and Notch1 in HE rats.